Global B2B Pharmaceutical Marketplace · Sourcing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Rifampicin bulk supplier for pharma manufacturers

Rifampicin 600 mg Suppliers & Bulk Manufacturers

Available Forms: Suspension

Available Strengths: 600 mg

Reference Brands: Rifadin Suspension (USA/EU/UK)

Category: Antibiotics

Rifampicin is an antibiotic. It is used in the treatment of tuberculosis and leprosy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

-

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

PharmaTradz lists GMP-certified manufacturers, suppliers and exporters of Rifampicin (reference brands: Rifadin Suspension (USA/EU/UK)). Post an RFQ to receive quotes from verified suppliers with export experience.

Rifampicin is available as Suspension in 600 mg. Availability for your market is confirmed at RFQ stage.

Yes — suppliers on PharmaTradz support bulk export with regulatory documentation such as COA, GMP certificates and CTD/ACTD dossiers where available. Share your destination market in your RFQ and we match you to suppliers able to serve it.

Related Products

Rifaximin

Strength:
100 mg/5 mL, 200 mg, 550 mg

Form: Tablet / Oral Suspension

Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)

View Details
Ceftaroline

Strength:
600 mg

Form: Injection

Reference Brands: Teflaro (USA), Zinforo (EU)

View Details
Secnidazole

Strength:
2 g

Form: Oral granules/ tablets

Reference Brands: Solosec (USA)

View Details
Omaveloxolone

Strength:
150 mg

Form: Tablets

Reference Brands: Skyclarys (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.